ON-TARGETplus Mouse Fdps (110196) siRNA - Individual,

Protocol tips

Upstream tips	Protocol tips	Downstream tips
	Four pure individual ON-TARGETplus siRNAs all designed to target murine FPPS (target sequences: siRNA1, 50 -GUC AAG UAC AAG ACG GCUU-30 ; siRNA2, 50 -GAA AAG AGG UAC AAA UCGA-30 ; siRNA3, 50 -AGA AAG UGA CCC CGG AAUU-30 ; siRNA4, 50 -CCU AGA GUA CAA UGC CUUA-30 ) and a nontargeting control siRNA (sense, 50 -UAG CGA CUA AAC ACA UCA AUU-30 ; antisense, 50 -UUA UCG CUG AUU UGU GUA GUU-30 ) were purchased from Dharmacon (USA). DharmaFECT 4 (DF4, Dharmacon) was used as the cationic lipid cell transfection reagent in complete media. Mature osteoclasts were prepared as described above, residual monocytes were removed from culture, and siRNA transfection was immediately performed. Transfection reagent DF4 and siRNA were prepared according to the manufacturer’s instructions (Dharmacon). Final dosing concentrations of all siRNAs provided to each well were 125 nM in a total volume of 1.0 μL of DF4. Cell uptake of siRNA complexes was performed by incubating cells with siRNA complexes in complete media with 30 ng/mL M-CSF and 200 ng/mL RANKL at 37 C with 5% CO2. Nonspecific knockdown from DF4 transfection was assessed by using nontargeting siRNA dosed under identical conditions. Multiple repeated siRNA cell transfections were performed on alternating days as specified in each figure legend. MC3T3-E1 cells were cultured at 4 104 cells/well in 24-well plates in complete media overnight. Transfections were performed early the next day. Final dosing concentrations of all siRNAs provided to each well were identical to osteoclasts. Cell uptake of siRNA complexes was performed by incubating the cells with siRNA complexes in complete media with 50 μg/mL AA and 10 mM β-glycerophosphate at 37 C with 5% CO2.

Protocol tips

Four pure individual ON-TARGETplus siRNAs all designed to target murine FPPS (target sequences: siRNA1, 50 -GUC AAG UAC AAG ACG GCUU-30 ; siRNA2, 50 -GAA AAG AGG UAC AAA UCGA-30 ; siRNA3, 50 -AGA AAG UGA CCC CGG AAUU-30 ; siRNA4, 50 -CCU AGA GUA CAA UGC CUUA-30 ) and a nontargeting control siRNA (sense, 50 -UAG CGA CUA AAC ACA UCA AUU-30 ; antisense, 50 -UUA UCG CUG AUU UGU GUA GUU-30 ) were purchased from Dharmacon (USA). DharmaFECT 4 (DF4, Dharmacon) was used as the cationic lipid cell transfection reagent in complete media. Mature osteoclasts were prepared as described above, residual monocytes were removed from culture, and siRNA transfection was immediately performed. Transfection reagent DF4 and siRNA were prepared according to the manufacturer’s instructions (Dharmacon). Final dosing concentrations of all siRNAs provided to each well were 125 nM in a total volume of 1.0 μL of DF4. Cell uptake of siRNA complexes was performed by incubating cells with siRNA complexes in complete media with 30 ng/mL M-CSF and 200 ng/mL RANKL at 37 C with 5% CO2. Nonspecific knockdown from DF4 transfection was assessed by using nontargeting siRNA dosed under identical conditions. Multiple repeated siRNA cell transfections were performed on alternating days as specified in each figure legend. MC3T3-E1 cells were cultured at 4 104 cells/well in 24-well plates in complete media overnight. Transfections were performed early the next day. Final dosing concentrations of all siRNAs provided to each well were identical to osteoclasts. Cell uptake of siRNA complexes was performed by incubating the cells with siRNA complexes in complete media with 50 μg/mL AA and 10 mM β-glycerophosphate at 37 C with 5% CO2.

Publication protocol

Four pure individual ON-TARGETplus siRNAs all designed to target murine FPPS (target sequences: siRNA1, 50 -GUC AAG UAC AAG ACG GCUU-30 ; siRNA2, 50 -GAA AAG AGG UAC AAA UCGA-30 ; siRNA3, 50 -AGA AAG UGA CCC CGG AAUU-30 ; siRNA4, 50 -CCU AGA GUA CAA UGC CUUA-30 ) and a nontargeting control siRNA (sense, 50 -UAG CGA CUA AAC ACA UCA AUU-30 ; antisense, 50 -UUA UCG CUG AUU UGU GUA GUU-30 ) were purchased from Dharmacon (USA). DharmaFECT 4 (DF4, Dharmacon) was used as the cationic lipid cell transfection reagent in complete media. Mature osteoclasts were prepared as described above, residual monocytes were removed from culture, and siRNA transfection was immediately performed. Transfection reagent DF4 and siRNA were prepared according to the manufacturer’s instructions (Dharmacon). Final dosing concentrations of all siRNAs provided to each well were 125 nM in a total volume of 1.0 μL of DF4. Cell uptake of siRNA complexes was performed by incubating cells with siRNA complexes in complete media with 30 ng/mL M-CSF and 200 ng/mL RANKL at 37
C with 5% CO2. Nonspecific knockdown from DF4 transfection was assessed by using nontargeting siRNA dosed under identical conditions. Multiple repeated siRNA cell transfections were performed on alternating days as specified in each figure legend. MC3T3-E1 cells were cultured at 4
104 cells/well in 24-well plates in complete media overnight. Transfections were performed early the next day. Final dosing concentrations of all siRNAs provided to each well were identical to osteoclasts. Cell uptake of siRNA complexes was performed by incubating the cells with siRNA complexes in complete media with 50 μg/mL AA and 10 mM β-glycerophosphate at 37
C with 5% CO2.

Full paper   Login or join for free to view the full paper.

Reviews

Discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing siRNA / miRNA gene silencing Mouse - MC3T3-E1 Fdps using ON-TARGETplus Mouse Fdps (110196) siRNA - Individual, from Horizon Discovery Ltd..

Manufacturer protocol

Download the product protocol from Horizon Discovery Ltd. for ON-TARGETplus Mouse Fdps (110196) siRNA - Individual, below.

Download manufacturer protocol

Videos

Check out videos that might be relevant for performing siRNA / miRNA gene silencing Mouse - MC3T3-E1 Fdps using ON-TARGETplus Mouse Fdps (110196) siRNA - Individual, from Horizon Discovery Ltd.. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.